Latest News On FDA

Latest California Healthline Stories

KHN’s ‘What The Health?’: Despite Booming Economy, Uninsured Rate Ticks Up

Nearly 2 million more Americans were uninsured in 2018 than in the previous year, according to the Census Bureau’s annual report. Plus, the Trump administration announced plans to ban flavored vape liquids, and Congress is back and working to address high prescription drug prices and “surprise” medical bills. This week, Joanne Kenen of Politico, Tami Luhby of CNN and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.

Mysterious Vaping Lung Injuries May Have Flown Under Regulatory Radar

Doctors who saw patients with a mysterious lung illness in the past suspected vaping as the cause but didn’t know where to report such cases. “It wasn’t that I didn’t want to report it, it’s that there’s no pathway,” said one California pulmonologist.

Shopping Abroad For Cheaper Medication? Here’s What You Need To Know

Americans routinely skirt federal law by crossing into Canada and Mexico or tapping online pharmacies abroad to purchase prescription medications at a fraction of the price they would pay at home. Is it safe? Not necessarily. Here’s some advice.

DIY Tech Gives People More Freedom In Managing Diabetes

People with diabetes say they’ve been waiting for years for better technology to manage their chronic condition. Tired of waiting, some tech-savvy, do-it-yourselfers are constructing their own devices using open-source programming instructions.

FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine

In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.